Download Cell-Free (In Vitro) Protein Expression

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Histone acetylation and deacetylation wikipedia , lookup

Proteasome wikipedia , lookup

SR protein wikipedia , lookup

Phosphorylation wikipedia , lookup

Signal transduction wikipedia , lookup

G protein–coupled receptor wikipedia , lookup

List of types of proteins wikipedia , lookup

Protein domain wikipedia , lookup

Magnesium transporter wikipedia , lookup

Protein wikipedia , lookup

Cyclol wikipedia , lookup

Protein folding wikipedia , lookup

Protein (nutrient) wikipedia , lookup

Protein structure prediction wikipedia , lookup

Intrinsically disordered proteins wikipedia , lookup

Protein phosphorylation wikipedia , lookup

Protein moonlighting wikipedia , lookup

Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup

Protein purification wikipedia , lookup

Western blot wikipedia , lookup

Proteolysis wikipedia , lookup

Protein–protein interaction wikipedia , lookup

Transcript
Cell-Free (In Vitro) Protein Expression How It Helps Speed Up Your Research
Gary Kobs
January 14, 2014
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
Presentation Overview
•
•
•
Cell-Free (In Vitro) Protein Expression Overview
•
Faster, easier protein expression with different systems to match your protein expression needs
•
Non-radioactive labeling and detection of expressed proteins
•
Key advantages of each system with data examples
Applications of Cell-Free Expressed Proteins
•
Protein:protein interaction studies
•
Protein:DNA binding studies
•
Assessment of viral IRES function
•
Structural studies
•
Ubiquitination analysis
•
Analysis of membrane proteins
•
Drug screening
HaloTag® Technology Overview
•
•
Combined Usage of HaloTag ® and Cell-Free Expressed Proteins
•
•
A unique, multi-functional protein fusion tag for global protein characterization
Protein kinase assays and inhibitor screen
Summary
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
2
Easiest/Fastest Method from DNA to Protein
 Saves valuable time
• Produce protein in 1-2 hours vs. days to
Cell-free
competent
plasmid
or
weeks in E. coli or mammalian cells
- None
Template
Label
-
35S-methionine
- Biotinylated lysines
- Fluor-labeled lysines
Cell-free competent
PCR product
TNT® System
Master Mix
•
•
•
•
•
• Use PCR product templates and bypass
cloning ORF into expression vector
 Produces sufficient protein for many
applications including:
• Protein:protein interactions
T7 RNA polymerase
Cellular lysate
Nucleotides
Amino acids
Energy regenerating system
1-2 hr @ 37°C Transcription/translation
• Co-IPs, pulldowns
• Protein:nucleic acid interactions
• Gel shift assays
• Enzymatic assays
 Enables analysis of difficult proteins
• Normally toxic to cells
• Insoluble in E. coli
Protein of Interest
 Simplifies detection
• Directly label protein during synthesis
Multiple Applications
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
• Fluorophore, 35S, biotin
3
Choices to Match Your Research Needs
Prokaryotic
Eukaryotic
Bacteria
Plant
Insect
Mammalian
E. coli
Wheat germ
Spodoptera frugiperda
Rabbit reticulocyte
S30 T7 High-Yield
Protein Expression
System
TNT® SP6 High-Yield
Wheat Germ
System
TNT® T7 Insect Cell
Extract System
TNT® Quick Coupled
T7 and SP6 Systems
Most active
protein
Native mammalian
system
Highest yield
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
Maximal
soluble protein
4
Faster Protein Production than E. coli Systems
E. coli Expression
Vector Prep
Template Prep
TNT® System
Analysis or
Purification
Analysis or
Purification
2 hrs
2 days
Critical Timeline
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
5
Maximal Yields from Each System
S30 T7 High-Yield Protein Expression System
TNT® SP6 High-Yield WG System
TNT ® T7 Insect Cell System
dialysis
TNT ® Quick
10
100
500
Protein Yield (µg/ml)
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
6
Characteristics of Cell-Free Expression Systems
System
Time
Yield
TNT® T7 or SP6 Quick
Coupled System (RRL)
1 hour
0.5µg/50µl
Any vector containing a T7 or SP6 promoter
upstream of coding sequence.
S30 High Yield
(Bacterial)
1 hour
25µg/50µl
T7 promoter-driven bacterial expression vector.
Can also use very active bacterial promoters (T5).
Highest yield with specialized vector containing
plant viral sequences (5.0µg/rxn). Greatest yield
using dialysis method (12.5µg/rxn).
TNT® SP6 High-Yield
Wheat Germ System
2 hours
5-12.5µg/50µl
TNT® T7 Insect Cell
System
4 hours
4.0µg/50µl
Optimized Wheat
Germ Vector
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
Requirements
Require use of a baculovirus expression vector
with T7 promoter upstream.
Insect Cell
Vector Example
7
Fluorescent Detection of Expressed Proteins
Non-Radioactive Co-translational Labeling
TNT® T7 Quick
Coupled
System
Proteins
expressed
TNTT7 Quick Coupled system
50kDa
50kDa
37kDa
38 kDa
37kDa
24 kDa
25kDa
25kDa
17 kDa
4
Proteins
5 Lysate
Only
Lysate only
FluoroTect™ Green
3
Protein 5
lys
2
Protein 4
1
lys
Protein 1
lys
52 kDa
Protein 3
Translation reaction +
FluoroTect™ GreenLys
tRNA
250kDa
150kDa
100kDa
75kDa
250kDa
102 kDa
150kDa
100kDa
76 kDa
75kDa
Protein 2
FluoroTect™
GreenLys tRNA
TNT S
 Produce active/detectable proteins without radioactivity
 Direct detection of fluorescently labeled proteins in gels
 Use in many applications including pulldowns, co-immunoprecipitations, mobility shift assays…
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
8
Indirect Detection of In Vitro Expressed Proteins
Transcend™ Biotin Co-translational Labeling
Proteins expressed
TNTT7 Quick Coupled system
TNT® SP6 Wheat Germ High-Yield System
Proteins expressed
TNT SP6 High Yield Wheat Germ system
102
kDa
102
kDa
102 kDa
Transcend™
7676
kDa
kDa
kDa
5252
kDa
Biotinylated tRNA
76 kDa
52 kDa
3838
kDa
kDa
1
2
3
4
Proteins
5 Lysate
Only
Lysate only
Lysate only
Protein 5
Protein 4
Biotin
Protein 3
lys
Protein 2
lys
Protein 1
lys
Protein 5
1717
kDa
kDa
17 kDa
Protein 4
tRNA
Protein 3
2424
kDa
kDa
Protein 2
Translation reaction +
24 kDa Transcend™ Biotinylated
Protein 1
38 kDa
 Produce active/detectable proteins without radioactivity
 Indirect detection of biotin labeled proteins using streptavidin conjugates (HRP, AlkPhos)
 Use in many applications including pull downs, co-immunoprecipitations, mobility shift assays…
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
9
Detection Sensitivity Rivaling 35S-Methionine
Fluorescent
5µl of reaction
Direct in-gel detection
Biotin, Indirect
1µl of reaction
Chemiluminescent Detection
20µCi 35S-Met
1µl of reaction
overnight exposure
Radioactive
Varying micrograms of firefly luciferase RNA were expressed
in the Rabbit Reticulocyte Lysate System, Nuclease Treated
(Cat. #L4960). Full details in Kobs, G., et al. (2001) Promega
Notes 77, 23-7.
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
10
What if There is a Lysine in the Active Site?
No Problem – Only 25-33% of Lysines are Labeled
FluoroTect™ & Transcend™ tRNA compete with natural lysyl
tRNA for incorporation into growing peptide chain
Lysine + Label
Lysine
25%-33% of
lysines get labeled
Precharged
Transcend™ or
FluoroTect™ tRNA
UUU
UUU
AAA/G
5’
3’
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
11
E. coli S30 Cell-Free Systems
High Yield System Amenable to HTS Applications
Key Advantages
Bacteria
• Highly efficient expression = high yield system
•
Great screening system
• Fast, suitable for HTS applications
• Open system that allows inclusion of additives
• Reported correlation with E. coli cell-based expression
S30 T7 High-Yield
Protein Expression
System
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
•
Well suited to protein labeling and large-scale production
•
Documented success in membrane protein production
General Vector/Template Requirements
•
T7 vectors for E. coli cell-based expression
•
Specialized vectors available
12
E. coli S30 Cell-Free Systems
Protein Expression/Purification
Manual
MagneHis™
Purification
Fluorescent
Detection
Cell-Free E. coli Expression
pFN6A-mgGFP
Clone
HQ
Monster
Green® GFP
S30 T7 High Yield System
Automated 1-16
Sample Purification
(Maxwell® 16)
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
13
Wheat Germ Cell-Free Systems
More Soluble Protein from an Animal-Free System
Key Advantages
Plant
• Full-length, soluble mammalian protein expression
•
High yield system (200µg/ml)
• Suitable for structural biology applications
•
Animal-free, eukaryotic system
General Vector/Template Requirements
TNT® SP6 High-Yield
Wheat Germ
System
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
•
SP6 or T7 promoter vectors depending on WG kit
•
Specialized vectors with plant viral 5’, 3’ UTRs for
higher expression available
14
Wheat Germ Cell-Free Systems
More Soluble Protein from an Animal-Free System
55/55 Proteins Expressed in TNT® SP6 High Yield WG System
55/55 soluble in
WG System!
Only 6/55 soluble
in E. coli cellbased expression
system
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
15
Insect Cell-Free Systems
Highly Active Protein from an Animal-Free System
Key Advantages
Insect
• Production of highly active, full-length proteins
•
Relatively high protein yields
• 75µg/ml in TNT® coupled system
•
Animal-free, eukaryotic system
General Vector/Template Requirements
TNT® T7 Insect Cell
Extract System
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
•
T7 promoter vectors
•
Specialized vectors available with baculovirus 5’, 3’
UTRs for higher expression
16
Insect Cell-Free Systems
Highly Active Protein from an Animal-Free System
Highest Specific Activity cPKA with T NT® T7 Insect Cell System
35
Protein Yield (WG>ICE>RR)
30
Tested:
ng/ul
25
TNT® SP6 High Yield Wheat Germ System
TNT® T7 Quick (Rabbit Retic.) System
TNT® T7 Insect Cell Extract System
20
15
10
5
Fold (specific activiy/TNTR)
0
5
4
3
WG
RR
ICE
no cAMP
cAMP
Specific Activity (ICE>RRWG)
2
1
0
WG
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
RR
ICE
17
Rabbit Retic (Mammalian) Cell-Free Systems
Mammalian Protein Expression in a Native Setting
Key Advantages
Mammalian
• Native system for mammalian proteins
•
Post-translational processing
• Adding canine microsomal membranes
•
Full-length protein expression likely
General Vector/Template Requirements
TNT® Quick Coupled
T7 and SP6 Systems
•
T7 or SP6 promoter vectors
•
T7 TNT® System: Compatible with many templates
•
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
A “Universal Lysate”
18
Rabbit Retic (Mammalian) Cell-Free Systems
“Universal Lysate” Suitable for Many T7 Vectors
Compatibility with Multiple T7 Expression Vectors
T7
Vector
Original
Use
Elements
TNT® Expression
Possible?
pF1A
E. coli
T7p-lacO-rbs-T7t
Y
pET15b-ffLuc
E. coli
T7p-lacO-rbs-HisTag-T7t
Y
pET32a
E. coli
T7p-lacO-rbs-Trx-T7t
Y
pET43.1a
E. coli
T7p-lacO-rbs-NusA-T7t
Y
pIVEX
S30 cell-free system
T7p-lacO-rbs-T7t
Y
pIX3.0
S30 cell-free system
T7p-lacO-rbs-T7t
Y
pIX4.0
Insect cell-free extract
T7p-
Y
pF3K
Wheat germ extract
T7p-Sp6p-BYDV5’-BYDV-3’-T7t
Y
pFN19K
Cell-free extracts
T7p-Sp6p-N-HT7-polyA
Y
pFC20K
Cell-free extracts
T7p-Sp6p-C-HT7-polyA
Y
pF4A
Mammalian
CMV-intron-T7p-SV40late polyA
Y
pRL-null
Mammalian
T7p-SV40late polyA
Y
pRL-CMV
Mammalian
CMV-T7p-SV40late polyA
Y
pRL-SV40
Mammalian
SV40-T7p-SV40late polyA
Y
pRL-TK
Mammalian
TK-T7p-SV40late polyA
Y
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
19
Rabbit Retic (Mammalian) Cell-Free Systems
Rapid Protein Expression/Functional Screening
Easily Test Expression Vectors Containing T7 Promoters w/TNT® T7 Quick
pET15b
pF1A
pF4A
His
Renilla luciferase
T7t
lacO
rbs
Renilla luciferase
T7t
Intron
T7p
lacO
T7p
T7p
CMVp
rbs
Renilla Expression
Renilla luciferase
SV40 Late PolyA
Signal
Renilla Luciferase Activity
16000
14000
12000
RLU
10000
8000
6000
4000
2000
0
control
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
pET15b
pF1A
pF4A
20
Cell-Free Technology and Detection Summary
Quickly Express Proteins in the System of Your Choice
 Go from DNA to usable protein in 1-4 hours
 Overcomes toxicity and insolubility issues associated with many proteins
 Multiple cell-free systems available to match your needs
• E. coli >>> Maximal protein yield
• Wheat Germ >>> Most soluble protein
• Insect Cells >>> Functionally active protein
• Rabbit Reticulocyte >>> Native mammalian system
 Simplify detection with co-translational biotin or fluorescent labeling
• Indirect detection or direct fluorescent detection
• Radioactive labeling with 35S-Met
 Western blotting detection using primary antibody to the expressed protein
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
21
Presentation Overview
•
•
•
Cell-Free (In Vitro) Protein Expression Overview
•
Faster, easier protein expression with different systems to match your protein expression needs
•
Non-radioactive labeling and detection of expressed proteins
•
Key advantages of each system with data examples
Applications of Cell-Free Expressed Proteins
•
Protein:protein interaction studies
•
Protein:DNA binding studies
•
Assessment of viral IRES function
•
Structural studies
•
Ubiquitination analysis
•
Analysis of membrane proteins
•
Drug screening
HaloTag® Technology Overview
•
•
A unique, multi-functional protein fusion tag for global protein characterization
Combined Usage of HaloTag® and Cell-Free Expressed Proteins
•
Protein kinase assays and inhibitor screen
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
22
Protein:Protein Interactions: Testing for Direct
Interaction of Asr1 with the RNAP II CTD
Daulny A., et al. (2008) Proc. Nat. Acad. Sci. 105, 19649-54
Key Experiments Using Cell-free Expressed Proteins
• Test for direct binding of Asr1 to the RNA Polymerase II CTD
• Analyze role of CTD phosphorylation in the interaction
• Used a cell-free expressed Asr1 protein in a Far Western assay to investigate
the interaction
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
23
Protein:Protein Interactions: Testing for Direct
Interaction of Asr1 with the RNAP II CTD
Experimental Design – Using Far Westerns to Detect Interactions
Purified GST, GST-CTD
WT & Ser2 & 5 mutant
proteins
GST
PO4
+/- Phosphorylation
E. coli
SDS-PAGE &
transfer to
membrane
Incubate
Wash
Detect bound
Asr1 by
autoradiography
35S
1 hour
+ 35S-Met
Asr1
TNT® T7 Quick
Coupled System
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
24
Protein:Protein Interactions: Testing for Direct
Interaction of Asr1 with the RNAP II CTD
Results
1. Asr1 binds directly to
the RNAP II CTD in a
phosphorylation
dependent manner
2. Mutation of Ser5 to
alanine prevents
phosphorylation at Ala5
& blocks Asr1 binding
3. Phosphorylation of
Ser2 plays less of a role
in promoting Asr1 binding
GST-CTD Fusion Protein:
CTD Phosphorylation:
Far Western Blot
Coomassie Stained Gel
(GSTΔ, GST-CTD Proteins)
A2 = Ser2 to Ala mutation
A5 = Ser5 to Ala mutation
Daulny A., et al. (2008) Proc. Nat. Acad. Sci. 105, 19649-54
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
25
Protein:DNA Binding and Protein:Protein
Interaction Analysis of AHRR1 Protein
Evans B., et al. (2008) Mol. Pharm. 73, 387-98
Key Experiments Using Cell-free Expressed Proteins
• Analyze DNA binding of AHHR1 (aryl hydrocarbon receptor repressor)
• Illustrate that a point mutation abolishes DNA binding activity
• Test and analyze the interaction of AHHR1 with ARNT2 using CoIP assay
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
26
Protein:DNA Binding: Testing the DNA
Binding Activity of AHHR1 and ARNT2
Experimental Design - Gel Shift Assays using
Cell-Free Expressed Proteins
1 hour
unlabeled
AHRR1
Wild Type
Y9F Mutant
TNT® T7 Quick
Coupled System
32P
Mix &
Incubate
1 hour
unlabeled
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
ARNT2
AHRR1
ARNT2
32P
Run in a nondenaturing
polyacrylamide gel &
autoradiograph
27
Protein:DNA Binding: Testing for AHHR1
DNA Binding Activity
Results
1. AHRR1 binds the
AHRE DNA binding site
only in the presence of
ARNT2b
2. Mutation of Tyr9 to
Phe abolishes DNA
binding
3. Supershift of the
complex with anti-AHHR1
Ab demonstrates AHRR1
is in the complex
Evans B., et al. (2008) Mol. Pharm. 73, 387-98
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
28
Protein:Protein Interactions: Testing for
Interaction of AHHR1 and ARNT2
Co-immunoprecipitation Assay
• Expressed full-length and deletion mutants
of AHRR1 using TNT® T7 Quick-Coupled
Rabbit Reticulocyte Lysate System
• 35S-met labeled AHRR1 proteins
• Expressed ARNT2 protein using same
system – unlabeled
AHHR1 FL
& Deletions
+
35S-Met
ARNT2
• Used anti-ARNT2 antibody in CoIP protein
complexes
• Detected Co-IP’d AHRR1 proteins by
SDS-gel & fluorography
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
29
Protein:Protein Interaction: Testing for
Interaction of AHHR1 and ARNT2
Results
Co-immunoprecipitation of
AHRR1 and ARNT2
1. AHRR1 & ARNT2
interact to form a
complex
2. Amino acids 189-270
are required for the
interaction
Evans B., et al. (2008) Mol. Pharm. 73, 387-98
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
30
In Vitro Functional Analysis of the CrPV IRES
Garrey J., et al. (2010) J. Virol. 84, 1124-38
Key Experiments Using Cell-free Expressed Proteins
• In vitro translation with dicistronic RNA containing viral IRES elements
• Used in vitro system to alter translation machinery and measure effects
• Transcribed/translated an additional protein and measured effect on IRES function
• Also used Dual Luciferase assay to measure levels of cell-free expression
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
31
In Vitro Functional Analysis of the CrPV IRES
Experimental Design – In Vitro Translation Assays
using Cell-Free Expression System
+/- 4E-BP1
Expression Plasmid
+/- IRES (CrPV or IGR)
RNA
30 min
+35S-Met
R luc
4E-BP1
FF luc
Dual-Luciferase Assays
R Luc + FF Luc
0, 30, 60 min
time points
TNT® T7 Quick
Coupled System
SDS gel followed by
autoradiography
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
32
In Vitro Functional Analysis of the CrPV IRES
Results
In Vitro Translation Data
1. Both IRES’s promote
translation of FF luc in
the second cistron
2. The IGR IRES is much
more active than the
CrPV IRES (5’UTR IRES)
3. 4E-BP1 disrupts
scanning-mediated
translation promoting
IRES-mediated translation
Garrey J., et al. (2010) J. Virol. 84, 1124-38
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
33
Generation of Labeled Proteins for Structural
Analysis by Solution NMR
Zhao, Li et al. (2010) Struc.Funct.Gen.11, 201-209
Key Experiments Using Cell-free Expressed Proteins
• Comparison of 59 human proteins for solubility and expression levels using wheat germ
extract or E. coli
• Scaled expression for 2 labeled proteins followed by NMR analysis
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
34
Use of Cell-Free for Structural Studies
Results
1.
Only 30% of proteins
produced soluble form
when using E.coli
2. 70% of proteins
produced soluble form
when using wheat germ
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
35
Ubiquitination Analysis of p73 Suppressor Protein
Jung, Y-S et al. (2011) J. Biol. Chem. 286, 35388-95
Key Experiments Using Cell-free Expressed Proteins
• In vitro translation of p73 with wild type and mutated Pirh2 in the presence of E1, E2
and ubiquitin
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
36
Use of Cell-Free for Ubiquitination Analysis
Results
1. 1PirH2 physically interacts with p73
2. Pirh2 promotes p73 polyubiquitination
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
37
Membrane Association of Pestivirus
Glycoprotein Erns
Tews, B-A. et al. (2007) J. Biol. Chem. 282, 32730-41
Key Experiments Using Cell-free Expressed Proteins
• In vitro translation of wild type Erns and Erns containing mutations
• Proteinase K protection assays in the presence of canine microsomal membranes
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
38
Membrane Association of Pestivirus
Glycoprotein Erns
Results
1. Proteinase K protection assays
showed show that Erns translated in the
presence of microsomal membranes was
protected
2. A mutant version containing a
artificial transmembrane region
and short cytosolic tail was
shortened by protease treatment
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
39
Characterizing Toxins: E. coli YoeB
Key Experiments Using Cell-free Expressed Proteins
•
Monitoring the effect toxins YoeB and MazF on protein synthesis in both prokaryotic
and eukaryotic cell-free systems
•
Determine if the antitoxin YefM inhibited YeoB activity
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
40
Use of Cell-Free Expression for Screening
Potential Toxins
Results
1. YefM antitoxin mediated YoeB
inhibition
2. YoeB is a specific inhibitor to
only prokaryotic protein
synthesis
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
41
Presentation Overview
• Cell-Free (In Vitro) Protein Expression Overview
• Faster, easier protein expression with different systems to match your protein
expression needs
• Non-radioactive labeling and detection of expressed proteins
• Key advantages of each system with data examples
• Applications of Cell-Free Expressed Proteins
• Protein: protein interaction studies
• Protein-DNA binding studies
• Assessment of viral IRES function
• HaloTag® Technology Overview
• A unique, multi-functional protein fusion tag for global protein characterization
• Combined Usage of HaloTag® and Cell-Free Expressed Proteins
• Protein kinase assays and inhibitor screen
• Summary
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
42
What is HaloTag® Technology?
A Unique, Multifunctional Protein Fusion Tag
HaloTag®:
• Engineered 34.1kDa
halophilic bacterial
hydrolase
• Binds to chloralkane
substrate and locks with
covalent attachment
HaloTag®
Protein of
Interest
+
N- or C- terminal
fusions
Chloroalkane
Linker
O
Cl
O
Functional
Group
Binding and…
• Faster kinetics than the
biotin:streptavidin
interaction
• No homolog in mammalian
cells = no background
Read more about the
development of this
powerful fusion tag:
Ohana, R.F., et al.
(2009) Prot. Exp. Purif.
68, 110-120.
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
Protein of
Interest
O
O
Functional
Group
Covalent bond between HaloTag® and
chloroalkane (+ functional group)
43
Many Functional Groups are Available to
Match Your Research Application(s)
Protein of
Interest
O
Functional
Group
O
O
Cl
O
HaloTag® Surfaces/Resins
Capture and Display
Protein arrays
Purification
Interaction analysis
O
Cl
O
Cl
Cl
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
HaloTag® Fluorescent Ligands
Labeling and Detection
O
Cellular imaging
Gel analysis
Quantitation
O
O
HaloTag® Reactive Ligands
Custom Modifications
O
Attach to particles, surfaces
Attach special ligands
44
Presentation Overview
• Cell-Free (In Vitro) Protein Expression Overview
• Faster, easier protein expression with different systems to match your protein
expression needs
• Non-radioactive labeling and detection of expressed proteins
• Key advantages of each system with data examples
• Applications of Cell-Free Expressed Proteins
• Protein: protein interaction studies
• Protein-DNA binding studies
• Assessment of viral IRES function
• HaloTag® Technology Overview
• A unique, multi-functional protein fusion tag for global protein characterization
• Combined Usage of HaloTag® and Cell-Free Expressed Proteins
• Protein kinase assays and inhibitor screen
• Summary
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
45
Enzymatic Assays
Measuring Protein Kinase A (PKA) Activity
Experimental Design – Immobilization of HaloTag®-cPKA
followed by Kinase Assays
Immobilized Enzyme
HT-cPKA
Expression Plasmid
HaloLink® Magnetic
Beads
Cl
O
cPKA
O
Kinase Assay
Measure
Remaining ATP
Kinase-Glo®
O
Incubate
O
Purify
cPKA
PKA
Activity
ADP
ATP
HaloTag®
TNT® SP6 High
Yield Wheat
Germ System
HaloLink™ Array
Slide
PKA Kinase Assay
OO
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
OO
OO
Promega Corporation
ProFluor®
PKA
Activity
46
Enzymatic Assays:
Testing for PKA Inhibitors
+/- Inhibitors
O O
WGE
ICE
Compound
U0126
H89
ProFluor® Kinase
Assay
Higher Bars = More
Inhibition
Target
MEK1/2
PKA specific
cPKA
Inhibition
No
Yes
PKI
PKA specific
Yes
Staurosporine
Non-selective
Kinase inhibitor
Yes
DMSO
No
100
20 ul particles
10 ul particles
80
0.3 u rPKA
0.075 u rPKA
60
40
WGE
20
0
U0126
Percent Maximum Signal (Inhibition)
cPKA
PKA Inhibitor Results
Percent Maximum Signal (Inhibition)
PKA Inhibitor Screening
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
PKI
st aurosporine
DMSO
Buf f er
Inhibitor (10 µM)
20 ul particles
80
10 ul particles
0.3 u rPKA
60
0.075 u rPKA
40
ICE
20
0
U0126
Donna M. Leippe, Kate Qin Zhao, Kevin Hsiao and Michael R. Slater.
Analytical Chemistry Insights (2010)5, 25-36
H89
100
H89
PKI
st aurosporine
DMSO
Buf f er
Inhibitor (10 µM)
47
Summary
• In vitro (cell-free) expression is an easy-to-use system to rapidly
produce full-length or deletion proteins of interest.
• Multiple cell-free systems are available to match your downstream
requirements.
• Cell-free expressed proteins are suitable for a wide array of
downstream applications.
• Protein:protein interaction studies, functional assays (e.g. kinase), protein:
nucleic acid binding… only limited by your creativity
• The combination of cell-free expression and HaloTag® is a powerful
tool for protein analysis.
• HaloTag® provides a multi-functional tag for in vivo analysis as well
• Protein interaction studies, cellular localization and trafficking, protein:nucleic
acid interactions…
Promega Corporation
©2013 Promega Corporation. Proprietary Information. Not for further distribution.
48